We looked at the association between clinical characteristics, demographic features, and genotype distribution of Notch1, 3, and 4 genes in CRC patients to evaluate whether Notch polymorphism played any role in the disease progression. This evidence concerns the gene NOTCH1 and colorectal carcinoma.